Breaking News Instant updates and real-time market news.

HCC

Warrior Met Coal

$22.80

-0.8914 (-3.76%)

07:25
04/13/18
04/13
07:25
04/13/18
07:25

Warrior Met Coal price target lowered to $32 from $39 at BMO Capital

BMO Capital analyst David Gagliano lowered his price target on Warrior Met Coal to $32, citing his adjustment post payment of the company's special dividend as the stock began trading ex-dividend today. The analyst notes that this payout brings the total special dividend payment to a 60% yield in the past 5 months, adding that it is a "a prudent" approach to returning capital to shareholders that do not overextend the balance sheet or expose the company during periods of high prices. Gagliano keeps his Outperform rating on Warrior Met Coal.

  • 02

    May

HCC Warrior Met Coal
$22.80

-0.8914 (-3.76%)

02/26/18
RBCM
02/26/18
NO CHANGE
Target $33
RBCM
Sector Perform
Warrior Met Coal price target raised to $33 from $25 at RBC Capital
RBC Capital analyst Sam Crittenden raised his price target on Warrior Met Coal to $33 after his site tour, stating that the company is well positioned to profit from higher metallurgical coal prices as operations have room to grow over the next few years. Crittenden adds that the company is well positioned to generate "strong" free cash flows and is positive on its plans to return excess cash to shareholders. The analyst keeps his Sector Perform rating on Warrior Met Coal based on its expected EBITDA multiple trading in line with peers.
02/22/18
SBSH
02/22/18
UPGRADE
Target $33
SBSH
Buy
Warrior Met Coal upgraded to Buy from Neutral at Citi
Citi analyst Alexander Hacking upgraded Warrior Met Coal to Buy and raised his price target for the shares to $33 from $23. The analyst views the company's 2018 guidance as conservative and notes his firm's global commodity team just raised their met coal prices forecasts. He expects the company's free cash flow to be directed towards shareholder returns.
02/15/18
BMOC
02/15/18
NO CHANGE
Target $39
BMOC
Outperform
Warrior Met Coal price target raised to $39 from $34 at BMO Capital
BMO Capital analyst David Gagliano raised his price target on Warrior Met Coal to $39 after Q4 earnings topped consensus while the company's FY18 operating targets were above estimates. Gagliano keeps his Outperform rating, noting that the company is undervalued based on its underappreciated free cash flow, organic growth potential, and clean balance sheet.
01/30/18
FBCO
01/30/18
NO CHANGE
Target $35
FBCO
Outperform
Warrior Met Coal price target to $35 from $18.75 at Credit Suisse
Credit Suisse analyst Curt Woodworth raised his price target for Warrior Met Coal to $35 from $18.75 to account for revised met coal forecasts. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

UNTY

Unity Bancorp

$19.85

0.065 (0.33%)

06:03
01/23/19
01/23
06:03
01/23/19
06:03
Earnings
Breaking Earnings news story on Unity Bancorp »

Unity Bancorp reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPX

Continental Building

$25.55

-0.32 (-1.24%)

06:03
01/23/19
01/23
06:03
01/23/19
06:03
Downgrade
Continental Building rating change  »

Continental Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHX

Athersys

$1.40

-0.03 (-2.10%)

06:02
01/23/19
01/23
06:02
01/23/19
06:02
Hot Stocks
Athersys reports 'positive' results from study of MultiStem cell therapy »

Athersys announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$34.45

-0.5 (-1.43%)

05:57
01/23/19
01/23
05:57
01/23/19
05:57
Downgrade
Toll Brothers rating change  »

Toll Brothers downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBR

KBR

$17.13

-0.48 (-2.73%)

05:56
01/23/19
01/23
05:56
01/23/19
05:56
Hot Stocks
KBR secures contract for K-SAAT »

KBR announced that it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFY

Infosys

$10.54

-0.14 (-1.31%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Hot Stocks
Infosys enters partnership with HPE GreenLake »

Infosys announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

WY

Weyerhaeuser

$24.55

-0.54 (-2.15%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Initiation
Weyerhaeuser initiated  »

Weyerhaeuser initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

SNE

Sony

$48.46

-1.705 (-3.40%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Hot Stocks
Sony announces formation of Sony Home Entertainment & Sound Products »

Sony Visual Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$36.43

-0.74 (-1.99%)

, LEN

Lennar

$43.48

-0.63 (-1.43%)

05:54
01/23/19
01/23
05:54
01/23/19
05:54
Upgrade
D.R. Horton, Lennar rating change  »

D.R. Horton upgraded to…

DHI

D.R. Horton

$36.43

-0.74 (-1.99%)

LEN

Lennar

$43.48

-0.63 (-1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

ZNGA

Zynga

$4.33

0.065 (1.53%)

05:53
01/23/19
01/23
05:53
01/23/19
05:53
Periodicals
Zynga founder raising up to $700M for new investment fund, Axios reports »

Zynga founder Mark Pincus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

YELP

Yelp

$35.37

-0.895 (-2.47%)

05:51
01/23/19
01/23
05:51
01/23/19
05:51
Periodicals
SCOTUS won't hear lawsuit over defamatory Yelp reviews, The Verge reports »

The Supreme Court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

HII

Huntington Ingalls

$196.46

-3.82 (-1.91%)

05:50
01/23/19
01/23
05:50
01/23/19
05:50
Downgrade
Huntington Ingalls rating change  »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

KCDMY

Kimberly-Clark de Mexico

$0.00

(0.00%)

05:49
01/23/19
01/23
05:49
01/23/19
05:49
Downgrade
Kimberly-Clark de Mexico rating change  »

Kimberly-Clark de Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDAIF

Daimler AG

$0.00

(0.00%)

05:47
01/23/19
01/23
05:47
01/23/19
05:47
Upgrade
Daimler AG rating change  »

Daimler AG upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEO

CNOOC

$161.22

-5.52 (-3.31%)

05:44
01/23/19
01/23
05:44
01/23/19
05:44
Hot Stocks
CNOOC announces 2019 business strategy, development plan »

CNOOC announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$35.83

-1.04 (-2.82%)

, AZN

AstraZeneca

$36.27

-0.28 (-0.77%)

05:43
01/23/19
01/23
05:43
01/23/19
05:43
Hot Stocks
Biohaven allowed to proceed with BHV-3241 Phase 3 clinical trial »

Biohaven Pharmaceutical…

BHVN

Biohaven Pharmaceutical

$35.83

-1.04 (-2.82%)

AZN

AstraZeneca

$36.27

-0.28 (-0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

ASML

ASML

$159.39

-3.34 (-2.05%)

05:38
01/23/19
01/23
05:38
01/23/19
05:38
Hot Stocks
ASML, Nikon, Carl Zeiss sign agreement to settle all litigation »

Nikon, ASML Holding, and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ASLN

Aslan Pharmaceuticals

$3.55

(0.00%)

05:36
01/23/19
01/23
05:36
01/23/19
05:36
Hot Stocks
Aslan says varlitinib pre-clinical data published online in Cancers »

Aslan Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAMR

Lamar Advertising

$73.53

-0.59 (-0.80%)

05:35
01/23/19
01/23
05:35
01/23/19
05:35
Recommendations
Lamar Advertising analyst commentary  »

Lamar Advertising price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 25

    Feb

ABBV

AbbVie

$88.70

-0.81 (-0.90%)

05:33
01/23/19
01/23
05:33
01/23/19
05:33
Initiation
AbbVie initiated  »

AbbVie assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 28

    Jan

  • 18

    May

PFE

Pfizer

$42.26

-0.26 (-0.61%)

05:31
01/23/19
01/23
05:31
01/23/19
05:31
Downgrade
Pfizer rating change  »

Pfizer downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

  • 18

    May

XOM

Exxon Mobil

$71.89

-1.09 (-1.49%)

05:30
01/23/19
01/23
05:30
01/23/19
05:30
Hot Stocks
Exxon Mobil, REG enter joint research agreement with Clariant »

ExxonMobil and Renewable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 10

    Feb

MYL

Mylan

$28.90

-0.68 (-2.30%)

05:30
01/23/19
01/23
05:30
01/23/19
05:30
Downgrade
Mylan rating change  »

Mylan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTS

Zoetis

$84.07

-0.55 (-0.65%)

05:29
01/23/19
01/23
05:29
01/23/19
05:29
Initiation
Zoetis initiated  »

Zoetis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

MDGL

Madrigal Pharmaceuticals

$114.07

-5.76 (-4.81%)

05:28
01/23/19
01/23
05:28
01/23/19
05:28
Initiation
Madrigal Pharmaceuticals initiated  »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.